Brief: Microtech Medical (Hangzhou) Says Linx Continuous Glucose Monitoring System Received Market Approval In Brazil
23/12/2025 15:25
Dec 23 (Reuters) - MicroTech Medical (Hangzhou) Co Ltd 2235.HK: LINX CONTINUOUS GLUCOSE MONITORING SYSTEM RECEIVED MARKET APPROVAL IN BRAZIL Further company coverage: 2235.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroTech Medical (Hangzhou)
See all newsBrief: MicroTech Medical (Hangzhou) Says AIDEX G9 Receives Marketing Approval From NMPA China
Brief: Microtech Medical (Hangzhou) Receives Marketing Approval In South Korea For Linx Glucose Monitoring System
Advisory: Alert incorrectly tagged to MicroTech Medical withdrawn
Brief: Microtech Medical (Hangzhou) Says Linx Continuous Glucose Monitoring System Received Market Approval In Brazil
Brief: Microtech Medical (Hangzhou) Says Linx System Received Market Approval In India